Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LASAGNA L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 68

  • Page / 3
Export

Selection :

  • and

PLACEBOS AND CONTROLLED TRIALS UNDER ATTACKLASAGNA L.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 6; PP. 373-374; BIBL. 5 REF.Article

DOSE-RELATED SLEEP DISTURBANCES INDUCED BY COFFEE AND CAFFEINE.LASAGNA L.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 21; NO 2; PP. 244Article

DRUGS FIVE YEARS LATER: PROPOXYPHENE NAPSYLATE.LASAGNA L.1976; ANN. INTERN. MED.; U.S.A.; DA. 1976; VOL. 85; NO 5; PP. 619-621; BIBL. 15 REF.Article

THE ROLE OF BENZODIAZEPINES IN NONPSYCHIATRIC MEDICAL PRACTICE.LASAGNA L.1977; AMER. J. PSYCHIATRY; U.S.A.; DA. 1977; VOL. 134; NO 6; PP. 656-658; BIBL. 20 REF.Article

REPORT OF A WORKSHOP ON FIXED-RATIO DRUG COMBINATIONS = RAPPORT D'UN SEMINAIRE SUR LES ASSOCIATIONS MEDICAMENTEUSES A RAPPORT FIXEDENGLER HJ; LASAGNA L.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 2; PP. 149-154; BIBL. 8REF.Article

Improving the drug development process: needed reformsLASAGNA, L.Drug information journal. 1995, Vol 29, Num 2, pp 415-424, issn 0092-8615Article

Clinical testing of products prepared by biotechnologyLASAGNA, L.Regulatory toxicology and pharmacology (Print). 1986, Vol 6, Num 4, pp 385-390, issn 0273-2300Article

TOWARD THE OPERATIONAL IDENTIFICATION OF ADVERSE DRUG REACTIONS.KARCH FE; LASAGNA L.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 21; NO 3; PP. 247-254; BIBL. 9 REF.Article

EVALUATING ADVERSE DRUG REACTIONSKARCH FE; LASAGNA L.1976; ADVERSE DRUG REACT. BULL.; G.B.; DA. 1976; NO 59; PP. 204-207; BIBL. 22 REF.Serial Issue

Macrocyclic molecules and their pharmacological applicationsLASAGNA, L.European journal of rheumatology and inflammation (English edition). 1993, Vol 12, Num 4, pp 3-5, issn 0140-1610Article

Is the social use of Marijuana dangerous or addicting?LASAGNA, L.Advances in alcohol & substance abuse. 1985, Vol 5, Num 1-2, pp 77-81, issn 0270-3106Article

ADVERSE DRUG REACTIONS. A CRITICAL REVIEWKARCH FE; LASAGNA L.1975; J. AMER. MED. ASS.; U.S.A.; DA. 1975; VOL. 234; NO 12; PP. 1236-1241; BIBL. 32 REF.Article

The desire to regulate: the wish to discoverLASAGNA, L.Drugs under experimental and clinical research. 1987, Vol 13, Num 11, pp 659-664, issn 0378-6501Article

A COMPARISON OF DRUG PRODUCT INFORMATION IN FOUR NATIONAL COMPENDIAALLOZA JL; LASAGNA L.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 269-277; BIBL. 20 REF.Article

THE QUANTIFICATION OF PAIN: AN ANALYSIS OF WORDS USED TO DESCRIBE PAIN AND ANALGESIA IN CLINICAL TRIALSKAMPON SRIWATANAKUL; KELVIE W; LASAGNA L et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 143-148; BIBL. 17 REF.Article

RELATIONSHIP OF SERUM AND MYOCARDIAL DIGOXIN CONCENTRATION TO ELECTROCARDIOGRAPHIC ESTIMATION OF DIGOXIN INTOXICATION.BIDDLE TL; WEINTRAUB M; LASAGNA L et al.1978; J. CLIN. PHARMACOL.; U.S.A.; DA. 1978; VOL. 18; NO 1; PP. 10-15; BIBL. 13 REF.Article

ESTROGEN PATIENT PACKAGE INSERT: MEDICATION ACCEPTANCE DESPITE NEGATIVE ATTITUDESWEINTRAUB M; GLICKSTEIN S; LASAGNA L et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 2; PP. 149-153; BIBL. 6 REF.Article

THE NORMAL VOLUNTEER IN CLINICAL INVESTIGATION: HOW RIGID SHOULD SELECTION CRITERIA BE. = LE VOLONTAIRE NORMAL DANS L'EXPERIMENTATION CLINIQUE: QUESTION DE LA RIGIDITE DES CRITERES DE SELECTIONJOUBERT P; RIVERA CALIMLIM L; LASAGNA L et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 3; PP. 253-257; BIBL. 8 REF.Article

Pharmaceutical regulation in the European Communauty : barriers to Single Market integrationKAITIN, K.I; LASAGNA, L.JOURNAL OF HEALTH POLITICS, POLICY AND LAW. 1992, Vol 17, Num 4, pp 847-868Article

Oral ciramadol in the treatment of postoperative painLASAGNA, L; CALIMLIM, J. F.Clinical pharmacology and therapeutics. 1985, Vol 38, Num 2, pp 176-182, issn 0009-9236Article

INTERNATIONAL CO-OPERATION IN DRUG TESTINGBINNS TB; GROSS F; LASAGNA L et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 2; PP. 333-334Article

Issues in pharmaceutical lotteries : The case of interferon beta-1bMANOCCHIA, M; LASAGNA, L.Clinical pharmacology and therapeutics. 1997, Vol 62, Num 3, pp 241-247, issn 0009-9236Article

Anorectic drugs: drug policy making at the state levelRICHARD, B. W; LASAGNA, L.Journal of clinical pharmacology. 1988, Vol 28, Num 5, pp 395-400, issn 0091-2700Article

Marijuana Policy and Drug MythologyLASAGNA, L; LINDZEY, G.Society. Trans-Action. Social Science and Modern Society St-Louis, Mo. 1983, Vol 20, Num 2, pp 67-78Article

The impact of regulations, tradition, and experimental design on clinical cancer trials : Report and recommendations resulting from Washington cancer trials conferenceLASAGNA, L; FREI, E. III.American journal of clinical oncology. 1996, Vol 19, Num 4, pp 325-329, issn 0277-3732Article

  • Page / 3